Cargando…

Vitamin K-Dependent Carboxylation of Osteocalcin in Bone—Ally or Adversary of Bone Mineral Status in Rats with Experimental Chronic Kidney Disease?

Chronic kidney disease (CKD) commonly occurs with vitamin K (VK) deficiency and impaired bone mineralization. However, there are no data explaining the metabolism of endogenous VK and its role in bone mineralization in CKD. In this study, we measured serum levels of phylloquinone (VK1), menaquinone...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ziemińska, Marta, Pawlak, Dariusz, Sieklucka, Beata, Chilkiewicz, Katarzyna, Pawlak, Krystyna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9572286/ https://www.ncbi.nlm.nih.gov/pubmed/36235734 http://dx.doi.org/10.3390/nu14194082

Ejemplares similares

Vitamin K and D Supplementation and Bone Health in Chronic Kidney Disease—Apart or Together?
por: Ziemińska, Marta, et al.
Publicado: (2021)

Modulation of the Paracrine Kynurenic System in Bone as a New Regulator of Osteoblastogenesis and Bone Mineral Status in an Animal Model of Chronic Kidney Disease Treated with LP533401
por: Mor, Adrian, et al.
Publicado: (2020)

Paracrine Kynurenic Pathway Activation in the Bone of Young Uremic Rats Can Antagonize Anabolic Effects of PTH on Bone Turnover and Strength through the Disruption of PTH-Dependent Molecular Signaling
por: Pawlak, Krystyna, et al.
Publicado: (2021)

Vitamin K alleviates bone calcium loss caused by Salmonella Enteritidis through carboxylation of osteocalcin
por: Liu, Yaojun, et al.
Publicado: (2021)

MM-129 as a Novel Inhibitor Targeting PI3K/AKT/mTOR and PD-L1 in Colorectal Cancer
por: Hermanowicz, Justyna Magdalena, et al.
Publicado: (2021)

Osteocalcin promotes bone mineralization but is not a hormone
por: Manolagas, Stavros C.
Publicado: (2020)

Preclinical Toxicity and Safety of MM-129—First-in-Class BTK/PD-L1 Inhibitor as a Potential Candidate against Colon Cancer
por: Hermanowicz, Justyna Magdalena, et al.
Publicado: (2021)

Apolipoprotein E and undercaboxylated osteocalcin are associated with bone fragility but not with bone mineral density in osteoarthritis patients
por: Rodrigues, Ana, et al.
Publicado: (2011)

The Changes of CTX, DPD, Osteocalcin, and Bone Mineral Density During the Postmenopausal Period
por: Park, Seok Gyo, et al.
Publicado: (2018)

Inverse association of serum osteocalcin and bone mineral density in renal transplant recipients
por: Lin, Wei-Chen, et al.
Publicado: (2022)

The Association between Elevated Levels of Peripheral Serotonin and Its Metabolite – 5-Hydroxyindoleacetic Acid and Bone Strength and Metabolism in Growing Rats with Mild Experimental Chronic Kidney Disease
por: Pawlak, Dariusz, et al.
Publicado: (2016)

Gamma-carboxylation regulates osteocalcin function
por: Lacombe, Julie, et al.
Publicado: (2015)

A link between central kynurenine metabolism and bone strength in rats with chronic kidney disease
por: Kalaska, Bartlomiej, et al.
Publicado: (2017)

The intensification of anticancer activity of LFM-A13 by erythropoietin as a possible option for inhibition of breast cancer
por: Rozkiewicz, Dariusz, et al.
Publicado: (2020)

Association between undercarboxylated osteocalcin, bone mineral density, and metabolic parameters in postmenopausal women
por: Zanatta, Leila C. B., et al.
Publicado: (2018)

Elevated Levels of Peripheral Kynurenine Decrease Bone Strength in Rats with Chronic Kidney Disease
por: Kalaska, Bartlomiej, et al.
Publicado: (2017)

Carboxylated and undercarboxylated osteocalcin in metabolic complications of human obesity and prediabetes
por: Razny, Urszula, et al.
Publicado: (2016)

Influence of Vitamin K on Bone Mineral Density and Osteoporosis
por: Elshaikh, Abeer O, et al.
Publicado: (2020)

Evaluation of Plasma Concentrations of Galectins-1, 2 and 12 in Psoriasis and Their Clinical Implications
por: Nowowiejska, Julia, et al.
Publicado: (2023)

Tumor Necrosis Factor (TNF) α, Endothelin (ET) 1 and α1-Acid Glycoprotein (AGP) as Potential Urine and Serum Markers of Metabolic Complications in Psoriasis?
por: Nowowiejska, Julia, et al.
Publicado: (2023)

Vitamin K Supplement Along with Vitamin D and Calcium Reduced Serum Concentration of Undercarboxylated Osteocalcin While Increasing Bone Mineral Density in Korean Postmenopausal Women over Sixty-Years-Old
por: Je, Sang Hyeon, et al.
Publicado: (2011)

Exploration of novel heterofused 1,2,4-triazine derivative in colorectal cancer
por: Hermanowicz, Justyna Magdalena, et al.
Publicado: (2021)

Osteocalcin—A Versatile Bone-Derived Hormone
por: Moser, Sarah C., et al.
Publicado: (2019)

Functions of Osteocalcin in Bone, Pancreas, Testis, and Muscle
por: Komori, Toshihisa
Publicado: (2020)

Sclerostin and Osteocalcin: Candidate Bone-Produced Hormones
por: Wang, Jialiang S., et al.
Publicado: (2021)

Association of nonalcoholic fatty liver disease with bone mineral density and serum osteocalcin levels in Korean men
por: Yang, Hae Jin, et al.
Publicado: (2016)

Gasdermin D (GSDMD) Is Upregulated in Psoriatic Skin—A New Potential Link in the Pathogenesis of Psoriasis
por: Nowowiejska, Julia, et al.
Publicado: (2023)

Gasdermin E (GSDME)—A New Potential Marker of Psoriasis and Its Metabolic Complications: The First Combined Study on Human Serum, Urine and Tissue
por: Nowowiejska, Julia, et al.
Publicado: (2023)

Ally to adversary: mesenchymal stem cells and their transformation in leukaemia
por: Sharma, Mugdha, et al.
Publicado: (2019)

Parents of children who are victims of trauma, allies or adversaries?
por: Ben Youssef, H., et al.
Publicado: (2023)

Differential Roles of Carboxylated and Uncarboxylated Osteocalcin in Prostate Cancer Growth
por: Hayashi, Yoshikazu, et al.
Publicado: (2016)

Drug-induced Reduction of Gamma Carboxylation in Osteocalcin: What is the Fallback?
por: Usman, Norina, et al.
Publicado: (2019)

Plasmacytoid dendritic cells during COVID-19: Ally or adversary?
por: Van der Sluis, Renée Marije, et al.
Publicado: (2022)

Undercarboxylated Osteocalcin and Its Associations With Bone Mineral Density, Bone Turnover Markers, and Prevalence of Osteopenia and Osteoporosis in Chinese Population: A Cross-Sectional Study
por: Xu, Yang, et al.
Publicado: (2022)

First evidence of octacalcium phosphate@osteocalcin nanocomplex as skeletal bone component directing collagen triple–helix nanofibril mineralization
por: Simon, Paul, et al.
Publicado: (2018)

Bone Regulates Glucose Metabolism as an Endocrine Organ through Osteocalcin
por: Shao, Jin, et al.
Publicado: (2015)

Human vascular cell responses to the circulating bone hormone osteocalcin
por: Millar, Sophie A., et al.
Publicado: (2019)

The impact of antihypertensive pharmacotherapy on interplay between protein-bound uremic toxin (indoxyl sulfate) and markers of inflammation in patients with chronic kidney disease
por: Kaminski, Tomasz W., et al.
Publicado: (2019)

Fatty Acid-Binding Protein 7 (FABP-7), Glutamic Acid and Neurofilament Light Chain (NFL) as Potential Markers of Neurodegenerative Disorders in Psoriatic Patients—A Pilot Study
por: Nowowiejska, Julia, et al.
Publicado: (2022)

The Potential Role of Serum Tau Protein (MAPT), Neuronal Cell Adhesion Molecule (NrCAM) and Neprilysin (NEP) in Neurodegenerative Disorders Development in Psoriasis—Preliminary Results
por: Baran, Anna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7jsdrvguru1sm3iiic7l4ilal0